| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,261 |
22,925 |
$2.77M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,839 |
18,223 |
$2.40M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,972 |
5,080 |
$1.80M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,642 |
8,837 |
$927K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,354 |
6,316 |
$857K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,052 |
2,822 |
$838K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,452 |
4,588 |
$785K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,934 |
2,452 |
$708K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,288 |
2,865 |
$675K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
6,688 |
2,061 |
$465K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,613 |
1,821 |
$395K |
| 80053 |
Comprehensive metabolic panel |
34,958 |
29,822 |
$375K |
| 59025 |
Fetal non-stress test |
2,480 |
1,363 |
$374K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,365 |
1,159 |
$331K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,321 |
1,179 |
$316K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,651 |
6,314 |
$305K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,487 |
3,540 |
$217K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
794 |
647 |
$210K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,809 |
824 |
$206K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
758 |
423 |
$182K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,644 |
6,314 |
$180K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,071 |
1,632 |
$163K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
799 |
645 |
$160K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,216 |
7,513 |
$153K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,382 |
771 |
$138K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
43,874 |
35,837 |
$136K |
| G0378 |
Hospital observation service, per hour |
1,680 |
806 |
$125K |
| 80061 |
Lipid panel |
7,391 |
6,907 |
$106K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13,228 |
11,557 |
$106K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
742 |
639 |
$103K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,531 |
3,249 |
$98K |
| 71046 |
Radiologic examination, chest; 2 views |
5,343 |
4,785 |
$96K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
5,311 |
5,068 |
$93K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,146 |
1,857 |
$93K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
372 |
341 |
$88K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
930 |
507 |
$80K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,138 |
962 |
$74K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,794 |
2,561 |
$73K |
| J3490 |
Unclassified drugs |
12,849 |
4,500 |
$72K |
| 82607 |
|
2,529 |
2,334 |
$67K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,128 |
4,209 |
$59K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,859 |
610 |
$55K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
562 |
475 |
$53K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
131 |
106 |
$50K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,240 |
1,176 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,370 |
3,607 |
$48K |
| 97016 |
|
1,351 |
348 |
$47K |
| 92526 |
|
1,642 |
537 |
$46K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
87 |
78 |
$46K |
| 74018 |
|
894 |
792 |
$43K |
| 84439 |
|
2,142 |
1,988 |
$42K |
| 87070 |
|
1,790 |
1,635 |
$41K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
892 |
792 |
$41K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
158 |
131 |
$36K |
| 97533 |
|
671 |
277 |
$33K |
| 73630 |
|
983 |
853 |
$31K |
| 96367 |
|
539 |
330 |
$29K |
| 87400 |
|
3,185 |
1,650 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,185 |
1,979 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
37,017 |
29,710 |
$27K |
| 80081 |
|
844 |
790 |
$26K |
| 97161 |
|
774 |
654 |
$25K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,326 |
11,603 |
$24K |
| 73610 |
|
758 |
639 |
$24K |
| 85027 |
|
2,077 |
1,954 |
$24K |
| 76642 |
|
199 |
183 |
$23K |
| 92557 |
|
388 |
367 |
$22K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
150 |
147 |
$22K |
| 92587 |
|
443 |
418 |
$22K |
| 84702 |
|
1,137 |
847 |
$21K |
| 86592 |
|
600 |
538 |
$20K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
894 |
832 |
$20K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
691 |
630 |
$20K |
| 84484 |
|
9,590 |
7,918 |
$20K |
| 73130 |
|
643 |
562 |
$20K |
| 72100 |
|
338 |
304 |
$19K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
67 |
40 |
$17K |
| 73030 |
|
487 |
425 |
$16K |
| 82728 |
|
1,262 |
1,150 |
$16K |
| 73560 |
|
383 |
335 |
$16K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,025 |
3,038 |
$16K |
| 87081 |
|
2,271 |
2,089 |
$16K |
| 97035 |
|
311 |
76 |
$15K |
| 87510 |
|
565 |
546 |
$15K |
| 93971 |
|
179 |
157 |
$14K |
| 82172 |
|
636 |
596 |
$14K |
| 94060 |
|
140 |
129 |
$14K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
72 |
68 |
$14K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
119 |
110 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,149 |
960 |
$13K |
| 86850 |
|
564 |
458 |
$13K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
891 |
829 |
$13K |
| 87077 |
|
1,332 |
1,141 |
$12K |
| 97014 |
|
343 |
110 |
$12K |
| 12001 |
|
94 |
69 |
$12K |
| 71250 |
|
227 |
200 |
$12K |
| 84481 |
|
772 |
726 |
$12K |
| 73110 |
|
369 |
320 |
$12K |
| 80076 |
|
794 |
697 |
$11K |
| 80320 |
|
1,376 |
1,073 |
$11K |
| 82553 |
|
1,882 |
1,581 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
6,580 |
5,640 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
895 |
793 |
$10K |
| 82950 |
|
697 |
650 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,274 |
1,198 |
$9K |
| 86140 |
|
1,063 |
864 |
$9K |
| 76830 |
Ultrasound, transvaginal |
142 |
125 |
$8K |
| 83540 |
|
1,202 |
1,066 |
$8K |
| 72131 |
|
210 |
163 |
$8K |
| 86900 |
|
678 |
547 |
$8K |
| 87480 |
|
565 |
546 |
$8K |
| 36591 |
|
1,637 |
885 |
$8K |
| 87660 |
|
566 |
547 |
$8K |
| 86803 |
|
339 |
301 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
721 |
601 |
$7K |
| 84466 |
|
1,164 |
1,039 |
$7K |
| 82677 |
|
200 |
185 |
$7K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
141 |
29 |
$7K |
| 84146 |
|
317 |
268 |
$7K |
| 94726 |
|
140 |
129 |
$7K |
| 94729 |
|
139 |
129 |
$7K |
| 82805 |
|
245 |
162 |
$6K |
| 83735 |
|
4,989 |
3,802 |
$6K |
| 84153 |
|
364 |
330 |
$6K |
| 43235 |
|
21 |
19 |
$6K |
| 87186 |
|
1,224 |
1,043 |
$6K |
| 82378 |
|
1,055 |
868 |
$6K |
| 95811 |
|
13 |
13 |
$6K |
| 97162 |
|
238 |
196 |
$6K |
| 76775 |
|
63 |
54 |
$6K |
| 73562 |
|
109 |
104 |
$5K |
| 74174 |
|
70 |
54 |
$5K |
| 82105 |
|
219 |
204 |
$5K |
| 76536 |
|
39 |
38 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
306 |
276 |
$5K |
| 73502 |
|
153 |
129 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,474 |
3,430 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
12 |
$5K |
| 97597 |
|
133 |
78 |
$4K |
| 85610 |
|
7,468 |
6,266 |
$4K |
| 82746 |
|
334 |
298 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
820 |
632 |
$4K |
| 72110 |
|
145 |
124 |
$4K |
| 72040 |
|
61 |
56 |
$4K |
| 83695 |
|
356 |
332 |
$4K |
| 86038 |
|
128 |
103 |
$4K |
| 82947 |
|
2,368 |
1,416 |
$3K |
| 92567 |
|
511 |
482 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
72 |
54 |
$3K |
| 83880 |
|
1,999 |
1,649 |
$3K |
| 86901 |
|
678 |
547 |
$3K |
| 82977 |
|
297 |
249 |
$3K |
| 85652 |
|
902 |
733 |
$3K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
25 |
24 |
$3K |
| 81001 |
|
11,976 |
10,243 |
$3K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
12 |
$3K |
| 86336 |
|
202 |
187 |
$3K |
| 83605 |
|
4,975 |
3,960 |
$3K |
| 12002 |
|
19 |
12 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,243 |
6,143 |
$3K |
| 96376 |
|
1,308 |
744 |
$3K |
| 84403 |
|
146 |
137 |
$3K |
| 99215 |
Prolong outpt/office vis |
41 |
39 |
$3K |
| 73090 |
|
146 |
119 |
$3K |
| 87340 |
|
97 |
79 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,180 |
10,210 |
$2K |
| 82570 |
|
261 |
216 |
$2K |
| 83001 |
|
94 |
85 |
$2K |
| 84436 |
|
416 |
340 |
$2K |
| 87040 |
|
2,003 |
1,266 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
35 |
27 |
$2K |
| 81025 |
|
6,724 |
5,687 |
$2K |
| 87807 |
|
225 |
215 |
$2K |
| 93017 |
|
30 |
27 |
$2K |
| 83690 |
|
6,695 |
5,627 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| 82565 |
|
212 |
180 |
$2K |
| 86618 |
|
120 |
99 |
$1K |
| 73590 |
|
108 |
82 |
$1K |
| 87205 |
|
403 |
339 |
$1K |
| 87147 |
|
176 |
139 |
$1K |
| 72072 |
|
28 |
27 |
$1K |
| 80069 |
|
85 |
60 |
$1K |
| 82043 |
|
156 |
148 |
$1K |
| 85018 |
|
202 |
161 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
380 |
370 |
$1K |
| 97165 |
|
39 |
29 |
$1K |
| 82550 |
|
5,036 |
4,203 |
$986.12 |
| 90715 |
|
53 |
43 |
$957.82 |
| 97116 |
|
30 |
12 |
$947.13 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,806 |
1,646 |
$919.54 |
| 81003 |
|
4,941 |
4,200 |
$863.13 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,010 |
1,527 |
$809.82 |
| 86677 |
|
40 |
36 |
$804.43 |
| 82784 |
|
46 |
40 |
$716.03 |
| A4452 |
Tape, waterproof, per 18 square inches |
261 |
159 |
$698.46 |
| 86780 |
|
26 |
25 |
$685.20 |
| 86431 |
|
37 |
30 |
$684.99 |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$662.49 |
| 82248 |
|
87 |
65 |
$661.76 |
| 84100 |
|
625 |
458 |
$628.37 |
| 85379 |
|
1,583 |
1,321 |
$595.38 |
| 71101 |
|
30 |
25 |
$573.39 |
| 83655 |
|
18 |
18 |
$532.59 |
| 87045 |
|
43 |
38 |
$523.97 |
| 84479 |
|
339 |
273 |
$519.15 |
| 84145 |
|
595 |
466 |
$481.37 |
| 80074 |
|
33 |
27 |
$478.82 |
| 82670 |
|
14 |
14 |
$469.34 |
| 77065 |
Tomosynthesis, mammo |
26 |
25 |
$468.42 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,290 |
4,476 |
$465.65 |
| 87493 |
|
32 |
27 |
$427.52 |
| 85730 |
|
6,226 |
5,263 |
$421.31 |
| 70486 |
|
44 |
37 |
$415.47 |
| 84460 |
|
98 |
68 |
$399.03 |
| 73140 |
|
19 |
12 |
$398.25 |
| 84402 |
|
15 |
15 |
$387.22 |
| 77062 |
|
14 |
12 |
$373.99 |
| 82247 |
|
54 |
36 |
$369.43 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,648 |
1,076 |
$365.22 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
10,665 |
8,158 |
$357.79 |
| 82150 |
|
674 |
587 |
$357.27 |
| 88141 |
|
14 |
12 |
$356.30 |
| 73552 |
|
46 |
28 |
$348.47 |
| 73080 |
|
12 |
12 |
$347.49 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
742 |
628 |
$341.96 |
| 00731 |
|
58 |
52 |
$334.64 |
| 00811 |
|
13 |
13 |
$334.64 |
| 82140 |
|
151 |
114 |
$304.17 |
| 86318 |
|
12 |
12 |
$303.70 |
| 74019 |
|
37 |
25 |
$303.57 |
| 88304 |
|
33 |
28 |
$291.96 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,906 |
3,740 |
$287.66 |
| 77066 |
Tomosynthesis, mammo |
68 |
58 |
$283.38 |
| 86787 |
|
16 |
13 |
$277.19 |
| 84450 |
|
70 |
51 |
$247.87 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
288 |
180 |
$233.03 |
| 86308 |
|
23 |
20 |
$230.85 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,758 |
1,430 |
$225.99 |
| 72128 |
|
35 |
25 |
$175.58 |
| 85014 |
|
40 |
24 |
$173.78 |
| A4649 |
Surgical supply; miscellaneous |
979 |
671 |
$148.17 |
| 88342 |
|
50 |
40 |
$147.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,099 |
5,799 |
$109.57 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,417 |
1,740 |
$105.28 |
| 87427 |
|
16 |
13 |
$98.96 |
| C9113 |
Injection, pantoprazole sodium, per vial |
180 |
130 |
$97.81 |
| 29125 |
|
12 |
12 |
$92.42 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
434 |
205 |
$82.69 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
512 |
398 |
$78.40 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
926 |
585 |
$73.31 |
| 84550 |
|
13 |
12 |
$66.74 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
569 |
455 |
$65.91 |
| 86300 |
|
17 |
13 |
$64.10 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
12 |
12 |
$60.76 |
| A6454 |
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard |
324 |
171 |
$60.05 |
| 80143 |
|
715 |
577 |
$52.38 |
| 84703 |
|
43 |
25 |
$52.04 |
| 36600 |
|
224 |
148 |
$48.56 |
| 83615 |
|
13 |
12 |
$43.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
564 |
372 |
$39.22 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
141 |
66 |
$37.74 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,424 |
1,682 |
$36.61 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
150 |
106 |
$35.06 |
| J2704 |
Injection, propofol, 10 mg |
2,403 |
1,758 |
$33.77 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
569 |
361 |
$33.73 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
682 |
454 |
$31.63 |
| 80179 |
|
702 |
565 |
$26.18 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
488 |
355 |
$18.31 |
| J7050 |
Infusion, normal saline solution, 250 cc |
737 |
392 |
$11.93 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,043 |
3,359 |
$7.28 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
139 |
107 |
$4.07 |
| 0353U |
|
40 |
38 |
$2.28 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
273 |
162 |
$1.33 |
| J3480 |
Injection, potassium chloride, per 2 meq |
59 |
40 |
$1.24 |
| A4602 |
Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each |
163 |
111 |
$0.62 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
43 |
42 |
$0.31 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
207 |
158 |
$0.06 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
14 |
14 |
$0.00 |
| A4550 |
Surgical trays |
213 |
148 |
$0.00 |
| 99152 |
|
12 |
12 |
$0.00 |
| 82010 |
|
33 |
24 |
$0.00 |
| 76942 |
|
42 |
26 |
$0.00 |
| 82800 |
|
100 |
68 |
$0.00 |
| A9270 |
Non-covered item or service |
2,041 |
1,608 |
$0.00 |
| A6452 |
High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard |
21 |
12 |
$0.00 |
| C1727 |
Catheter, balloon tissue dissector, non-vascular (insertable) |
154 |
116 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
26 |
12 |
$0.00 |
| A4616 |
Tubing (oxygen), per foot |
190 |
152 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
114 |
58 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
62 |
62 |
$0.00 |
| 00813 |
|
86 |
72 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
125 |
78 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
99 |
67 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
15 |
12 |
$0.00 |